We can’t show the full text here under this license.
Abstract
Risperidone nano-microparticles may improve therapeutic effectiveness by enhancing solubility at the administration site.
- Drugs classified under BCS Class II often have low absorption efficiency due to limitations in the dissolution phase.
- Nanocarriers are proposed as a means to enhance drug delivery for disease diagnostics, therapy, and prevention.
- The review discusses pharmaceutical compositions of risperidone nano-microparticles aimed at alleviating psychosis.
- Potential future developments in drug delivery technologies are also highlighted.
Simplified